Clinical Trials Browser

Interventional × fluorodopa F 18 × 1 year × Clear all

Endocrine System Diseases, Pheochromocytoma

NCT06667726 2026-03-16

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Phase 2 Not yet recruiting

47 enrolled

CNS

Brain Neoplasms

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

Phase 3 Recruiting

800 enrolled

CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

NCT05781321 2026-02-03

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Phase 2 Active not recruiting

170 enrolled

CNS

Glioblastoma

NCT07025226 2026-01-26

Senolytics

Phase EARLY_PHASE1 Recruiting

10 enrolled

CNS

Glioma

NCT05088798 2025-12-19

18FDOPA HI

Phase 2 Recruiting

100 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT02856347 2025-11-18

CMTpostopFDOPA

Phase NA Completed

24 enrolled

Carcinoma, Medullary

NCT01991977 2025-10-20

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Phase 2 Completed

91 enrolled 14 charts

CNS

Glioma

NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Phase EARLY_PHASE1 Completed

24 enrolled

CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT03778294 2025-07-03

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy